ReviewDrug design, development and therapy2015

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Konstantinos Dimitropoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.